United Cannabis Begins Clinical Trials On Prana P1 THC Activated Capsules


DENVER, CO — /D.M.O. Newswire/ — August 1, 2018 / United Cannabis Corporation (OTC:CNAB) (the “Company” or “United Cannabis”) today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica’s University of the West Indies.


The study, titled, “An Open Label, Phase 1, 2-Way crossover study evaluating the pharmacokinetics of Prana P1 THC activated capsules,” is be conducted in conjunction with Cannabinoid Research Development (“CRD”), the Company’s Jamaican subsidiary, at the Centre For Cannabis Research at the University’s Mona Campus.


Earnest Blackmon, Chief Executive Officer of United Cannabis, commented on the announcement, “We are very proud to announce the commencement of our clinical trials; we have been working toward this goal since we started the

... read more at: https://www.dailymarijuanaobserver.com/single-post/2018/08/01/CNAB-United-Cannabis-Begins-Clinical-Trials-On-Prana-P1-THC-Activated-Capsules